ProShares has launched the Ultra CRCL ETF (CRCA), a new exchange-traded fund designed to double the daily performance of Circle's (CRCL) stock. This allows traders to make leveraged bets on the company, which specializes in crypto finance, particularly with its USDC stablecoin. Circle's stock has surged 134% since its IPO on the New York Stock Exchange (NYSE), driven by growing adoption of its stablecoin and recent legislative support for digital payments.

*Key Details About CRCA:*

- *Ticker Symbol:* CRCA

- *Tracking Index:* Circle's stock performance

- *Leverage:* 2x daily performance

- *Trading Platform:* NYSE

*Market Context:*

- The GENIUS Act has provided a legal framework for payment stablecoins, clarifying how firms like Circle can operate in the US financial system.

- Leveraged ETFs like CRCA are designed for short-term trading and may not be suitable for long-term investing due to daily rebalancing.

*Circle's Performance:*

- *Current Stock Price:* $161.71 (up 5.05% in the past 24 hours)

- *Market Capitalization:* $35.87 billion

- *52-Week Range:* $64.00 - $298.99

¹ ²

*Analyst Sentiment:*

- *Consensus Rating:* Hold

- *Price Target:* $169.00 (4.51% upside)

- *Analyst Coverage:* 14 analysts covering CRCL stock ¹#crcl